Narayana Hrudayalaya has reported a robust financial performance for the year ended March 31, 2026, with a consolidated net profit of ₹8,059.79 million. The company has recommended a final dividend of ₹4.50 per share for its shareholders. Additionally, the board has approved plans to raise up to ₹1,500 crore through debt securities to support future growth and operations.
Financial Highlights
For the financial year ended March 31, 2026, Narayana Hrudayalaya achieved a consolidated revenue from operations of ₹78,960.35 million, marking a significant increase over the previous year. The consolidated net profit for the year stood at ₹8,059.79 million. On a standalone basis, the company reported an annual revenue of ₹39,751.41 million and a net profit of ₹5,031.13 million for the same period.
Dividend and Shareholder Information
The Board of Directors has recommended a final dividend of ₹4.50 per share for the fiscal year 2026. This proposal is subject to approval at the upcoming 26th Annual General Meeting, which is scheduled for August 14, 2026. The company has set July 17, 2026, as the record date to determine shareholder eligibility for the dividend payout.
Strategic Growth and Governance
To support its expansion initiatives, the company received approval to raise funds via debt securities, including Non-Convertible Debentures (NCDs), up to an amount of ₹1,500 crore within a single financial year. Furthermore, the board has approved the re-appointment of Ms. Terri Smith Bresenham as an Independent Director for a second five-year term, effective August 5, 2026, ensuring leadership continuity.
Operational Updates
The company continues to focus on its core ‘Medical and Healthcare Related Services’ segment. Key operational developments include the successful completion of the merger process for Meridian Medical Research & Hospital Limited and ongoing strategic acquisitions to bolster the company’s network, including expansions in the United Kingdom and Cayman Islands to enhance service delivery and clinical outcomes.
Source: BSE
